Short interest in Corvus Pharmaceuticals Inc (NASDAQ:CRVS) increased during the last reporting period, rising from 2.44M to 2.93M. This put 5.8% of the company's publicly available shares short.

Short interest for Corvus Pharma gives investors a sense of the degree to which investors are betting on the decline of Corvus Pharma's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 1.06M shares traded per day, it would take 2.77 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.